Alexza Pharmaceuticals Company Profile (NASDAQ:ALXA)

About Alexza Pharmaceuticals

Alexza Pharmaceuticals logoAlexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of products for the acute treatment of central nervous system conditions. The Company's product candidates are based on the Staccato system technology. Its product candidates in development include AZ-002, which contains alprazolam as an active pharmaceutical ingredient (API) is developed for the management of patients with acute repetitive seizures, and AZ-007, which contains zaleplon as API is developed for the treatment of insomnia in patients who have difficulty falling asleep, including those patients with middle of the night awakening having difficulty falling back asleep. Its product also includes ADASUVE, which contains loxapine as API is developed for the treatment of agitation associated with schizophrenia or bipolar disorder. It has initiated a Phase IIa proof-of-concept study for AZ-002 in patients with epilepsy and has completed Phase I testing for AZ-007.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ALXA
  • CUSIP:
Key Metrics:
  • Previous Close: $0.94
  • 50 Day Moving Average: $0.940
  • 200 Day Moving Average: $0.733
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.80
  • P/E Growth: 0.000
  • Market Cap: $N/A
Additional Links:
Companies Related to Alexza Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Alexza Pharmaceuticals (NASDAQ:ALXA) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Alexza Pharmaceuticals (NASDAQ:ALXA)
Show:
DateFirmActionRatingPrice TargetDetails
3/27/2015Roth CapitalSet Price TargetHold$2.50View Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for Alexza Pharmaceuticals (NASDAQ:ALXA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016        
5/11/2016Q116($0.16)ViewN/AView Earnings Details
3/28/2016Q415($0.37)($0.15)$1.45 millionViewListenView Earnings Details
11/5/2015Q315($0.34)($0.27)$1.60 million$1.77 millionViewN/AView Earnings Details
8/6/2015Q215($0.60)($0.63)$1.49 millionViewN/AView Earnings Details
5/6/2015Q115($0.51)($0.02)$3.36 millionViewN/AView Earnings Details
3/9/2015Q414($0.68)($0.35)$2.99 million$1.45 billionViewN/AView Earnings Details
11/5/2014Q3($0.74)($0.77)ViewListenView Earnings Details
8/7/2014Q2($0.67)($0.34)$2.24 million$1.50 millionViewListenView Earnings Details
5/5/2014Q1($0.55)($0.55)ViewListenView Earnings Details
11/6/2013Q313($0.54)($0.72)$1.98 million$2.20 millionViewListenView Earnings Details
8/8/2013Q2 2013$0.09($0.21)$14.17 million$40.84 millionViewListenView Earnings Details
5/9/2013Q1 2013($0.45)($1.31)$1.00 million$0.73 millionViewListenView Earnings Details
11/7/2012Q312($0.52)$1.86 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alexza Pharmaceuticals (NASDAQ:ALXA)
Current Year EPS Consensus Estimate: $-2.110 EPS
Next Year EPS Consensus Estimate: $-1.170 EPS

Dividends

Dividend History for Alexza Pharmaceuticals (NASDAQ:ALXA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alexza Pharmaceuticals (NASDAQ:ALXA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2016Ferrer Internacional S GrupoMajor ShareholderBuy19,465,714$0.90$17,519,142.60View SEC Filing  
9/6/2013Gordon RingoldDirectorBuy10,000$4.77$47,700.00View SEC Filing  
7/26/2013Thomas Braxton KingCEOBuy40,000$4.48$179,200.00View SEC Filing  
7/26/2013Thomas Braxton KingCEOBuy40,000$4.48$179,200.00View SEC Filing  
1/18/2013Lansdowne Partners Austria GmbMajor ShareholderSell125,000$4.75$593,750.00View SEC Filing  
12/27/2012Lansdowne Partners Austria GmbMajor ShareholderBuy72,189$4.85$350,116.65View SEC Filing  
12/26/2012James V CassellaEVPSell4,558$4.90$22,334.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Alexza Pharmaceuticals (NASDAQ:ALXA)
DateHeadline
News IconHercules Provides Portfolio Update for Q2 2016 and Highlights Continued Execution of Its Portfolio and Earnings Growth Strategy (NASDAQ:ALXA)
www.pymnts.com - July 5 at 3:24 PM
publicnow.com logoDelisting of Securities of Alexza Pharmaceuticals, Inc., MOKO Social Media Ltd., Hercules Offshore, Inc., FreeSeas Inc., and Pacific Sunwear of California, Inc. from The Nasdaq Stock Market (NASDAQ:ALXA)
www.publicnow.com - July 1 at 4:31 PM
publicnow.com logoDelisting of Securities of Alexza Pharmaceuticals, Inc. from The Nasdaq Stock Market (NASDAQ:ALXA)
www.publicnow.com - July 1 at 4:21 PM
streetinsider.com logoGrupo Ferrer to Acquire Alexza Pharma (ALXA) for 90c/Share (NASDAQ:ALXA)
www.streetinsider.com - June 22 at 3:27 PM
finance.yahoo.com logoALEXZA PHARMACEUTICALS INC. Financials (NASDAQ:ALXA)
finance.yahoo.com - June 22 at 1:04 PM
biz.yahoo.com logoALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisti (NASDAQ:ALXA)
biz.yahoo.com - June 21 at 8:55 AM
finance.yahoo.com logoAlexza Pharmaceuticals Acquired by Ferrer (NASDAQ:ALXA)
finance.yahoo.com - June 21 at 8:00 AM
4-traders.com logoALEXZA PHARMACEUTICALS INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) (NASDAQ:ALXA)
www.4-traders.com - June 17 at 3:25 PM
biz.yahoo.com logoALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or (NASDAQ:ALXA)
biz.yahoo.com - June 16 at 4:10 PM
capitalcube.com logoAlexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 (NASDAQ:ALXA)
www.capitalcube.com - June 1 at 12:51 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alexza Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm for Additional Information (NASDAQ:ALXA)
finance.yahoo.com - May 16 at 10:10 PM
finance.yahoo.com logoALEXZA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Ferrer Pharma, Inc. May be Unfair to Shareholders (NASDAQ:ALXA)
finance.yahoo.com - May 16 at 1:01 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alexza Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information (NASDAQ:ALXA)
finance.yahoo.com - May 13 at 11:15 PM
biz.yahoo.com logoALEXZA PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ALXA)
biz.yahoo.com - May 13 at 4:04 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of Alexza Pharmaceuticals, Inc. to Ferrer Pharma, Inc. - ALXA (NASDAQ:ALXA)
finance.yahoo.com - May 13 at 10:59 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Alexza Pharmaceuticals, Inc. -ALXA (NASDAQ:ALXA)
finance.yahoo.com - May 12 at 10:15 PM
publicnow.com logoAlexza Reports 2016 First Quarter Financial Results (NASDAQ:ALXA)
www.publicnow.com - May 11 at 5:17 PM
biz.yahoo.com logoQ1 2016 Alexza Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:ALXA)
biz.yahoo.com - May 11 at 7:07 AM
finance.yahoo.com logoWhy is Alexza Pharmaceuticals (ALXA) Stock Soaring Today? (NASDAQ:ALXA)
finance.yahoo.com - May 10 at 3:59 PM
publicnow.com logoAlexza to Cancel 2016 First Quarter Financial Results Earnings Call (NASDAQ:ALXA)
www.publicnow.com - May 10 at 8:48 AM
biz.yahoo.com logoALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material (NASDAQ:ALXA)
biz.yahoo.com - May 10 at 6:15 AM
News IconAlexza Pharmaceuticals, Inc. (ALXA) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:ALXA)
www.sharetrading.news - April 26 at 12:10 PM
benzinga.com logoWorst Performing Industries For April 26, 2016 - Benzinga (NASDAQ:ALXA)
www.benzinga.com - April 26 at 12:10 PM
News IconLatest Analyst Ratings For Alexza Pharmaceuticals, Inc. (ALXA) - Share Trading News (NASDAQ:ALXA)
www.sharetrading.news - April 22 at 12:00 PM
News IconAlexza Pharmaceuticals, Inc. (ALXA) – Broker Update - Risers & Fallers (NASDAQ:ALXA)
www.risersandfallers.com - April 22 at 12:00 PM
News IconBroker Roundup For Alexza Pharmaceuticals, Inc. (ALXA) - Share Trading News (NASDAQ:ALXA)
www.sharetrading.news - April 15 at 2:53 PM
News IconAlexza Pharmaceuticals, Inc. (ALXA) Latest Broker Coverage - Risers & Fallers (NASDAQ:ALXA)
www.risersandfallers.com - April 12 at 2:48 PM
News IconAnalyst Coverage: Alexza Pharmaceuticals, Inc. (ALXA) - Risers & Fallers (NASDAQ:ALXA)
www.risersandfallers.com - April 12 at 2:48 PM
News IconAlexza Pharmaceuticals Incorporated (NASDAQ:ALXA) Shorted Shares Decreased By 23.66% - Stock Caller (NASDAQ:ALXA)
www.stockcaller.com - April 8 at 3:02 PM
clintongazette.com logoAlexza Pharmaceuticals Incorporated (NASDAQ:ALXA) Shorts Decreased by 23.66% After Short Covering - Clinton Financial (NASDAQ:ALXA)
www.clintongazette.com - April 2 at 2:45 PM
capitalcube.com logoAlexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q4, 2015 By the Numbers (NASDAQ:ALXA)
www.capitalcube.com - March 30 at 1:04 PM
capitalcube.com logoAlexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:ALXA)
www.capitalcube.com - March 30 at 11:47 AM
publicnow.com logoAlexza Reports Fourth Quarter and Year End 2015 Financial Results (NASDAQ:ALXA)
www.publicnow.com - March 28 at 4:22 PM
biz.yahoo.com logoQ4 2015 Alexza Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:ALXA)
biz.yahoo.com - March 28 at 7:07 AM
biz.yahoo.com logoALEXZA PHARMACEUTICALS INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements an (NASDAQ:ALXA)
biz.yahoo.com - March 24 at 4:14 PM
finance.yahoo.com logoAlexza to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016 (NASDAQ:ALXA)
finance.yahoo.com - March 15 at 5:00 PM
News IconAlexza Pharmaceuticals Inc (NASDAQ:ALXA) 2015 Q3 Institutional Investor Sentiment Steady - RiversideGazette.com (NASDAQ:ALXA)
www.riversidegazette.com - March 15 at 12:56 PM
News IconAlexza Pharmaceuticals Incorporated (NASDAQ:ALXA) Sellers Covered 4.31% of Their Shorts - RiversideGazette.com (NASDAQ:ALXA)
www.riversidegazette.com - March 14 at 9:56 AM
finance.yahoo.com logoAlexza Pharmaceuticals Receives Positive Nasdaq Listing Determination (NASDAQ:ALXA)
finance.yahoo.com - March 9 at 5:00 PM
clintongazette.com logoAlexza Pharmaceuticals Incorporated (NASDAQ:ALXA) Shorted Shares Increased By 14.5% - Clinton Financial (NASDAQ:ALXA)
www.clintongazette.com - February 28 at 2:01 PM
benzinga.com logoAlexza Pharmaceuticals Confirms Grupo Ferrer Non-binding LoI - Benzinga (NASDAQ:ALXA)
www.benzinga.com - February 28 at 2:01 PM
thestreet.com logoAlexza Pharmaceuticals Confirms Grupo Ferrer Non-binding Letter Of Intent (NASDAQ:ALXA)
www.thestreet.com - February 26 at 8:55 PM
streetinsider.com logoAlexza Pharma (ALXA) Reacquires ADASUVE Rights from Teva - StreetInsider.com (NASDAQ:ALXA)
www.streetinsider.com - February 24 at 2:40 PM
biz.yahoo.com logoALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equi (NASDAQ:ALXA)
biz.yahoo.com - February 24 at 9:09 AM
finance.yahoo.com logoAlexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder (NASDAQ:ALXA)
finance.yahoo.com - February 24 at 8:00 AM
finance.yahoo.com logoAlexza Pharmaceuticals Inc. (ALXA) (NASDAQ:ALXA)
finance.yahoo.com - February 13 at 12:59 PM
News IconAnalyst Coverage Updates - Alexza Pharmaceuticals, Inc. (ALXA) - Risers & Fallers (NASDAQ:ALXA)
www.risersandfallers.com - February 11 at 1:04 PM
News IconAlexza Pharmaceuticals Incorporated (NASDAQ:ALXA) Short Interest Increased By 5.69% - fdanewsalert.com (NASDAQ:ALXA)
www.fdanewsalert.com - February 6 at 12:41 PM
finance.yahoo.com logoNew Strong Buy Stocks for December 29th (NASDAQ:ALXA)
finance.yahoo.com - December 29 at 9:30 AM
finance.yahoo.com logoNew Strong Buy Stocks for December 24th (NASDAQ:ALXA)
finance.yahoo.com - December 24 at 9:30 AM

Social

Alexza Pharmaceuticals (NASDAQ:ALXA) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff